Rep. Bruce Westerman Purchases Shares of Roche Holding AG (OTCMKTS:RHHBY)
by Scott Moore · The Cerbat GemRepresentative Bruce Westerman (R-Arkansas) recently bought shares of Roche Holding AG (OTCMKTS:RHHBY). In a filing disclosed on April 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in Roche stock on March 3rd. The trade occurred in the Representative’s “FISHER IRA” account.
Representative Bruce Westerman also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) on 4/2/2025.
- Purchased $1,001 – $15,000 in shares of Sony Group (NYSE:SONY) on 3/24/2025.
- Purchased $1,001 – $15,000 in shares of Mitsubishi UFJ Financial Group (NYSE:MUFG) on 3/21/2025.
- Purchased $1,001 – $15,000 in shares of BP (NYSE:BP) on 3/21/2025.
- Sold $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 3/20/2025.
- Sold $1,001 – $15,000 in shares of Medtronic (NYSE:MDT) on 3/20/2025.
- Purchased $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 3/20/2025.
- Sold $1,001 – $15,000 in shares of Visa (NYSE:V) on 3/20/2025.
- Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 3/20/2025.
- Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 3/20/2025.
Roche Trading Up 0.8 %
RHHBY stock traded up $0.32 during mid-day trading on Friday, reaching $38.90. 2,893,783 shares of the company traded hands, compared to its average volume of 3,169,930. The firm’s 50 day moving average price is $40.93 and its 200 day moving average price is $38.55. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $44.31.
Wall Street Analyst Weigh In
Several research firms recently commented on RHHBY. Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a research note on Thursday, January 30th. UBS Group raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Finally, Morgan Stanley initiated coverage on Roche in a research report on Wednesday, February 12th. They set an “equal weight” rating for the company. Two research analysts have rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy”.
View Our Latest Stock Report on RHHBY
Institutional Investors Weigh In On Roche
Several institutional investors have recently modified their holdings of the business. Bard Financial Services Inc. increased its position in Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock valued at $5,716,000 after acquiring an additional 28,050 shares during the last quarter. GAMMA Investing LLC raised its position in Roche by 59.5% in the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company’s stock worth $529,000 after acquiring an additional 4,794 shares during the period. Fulton Bank N.A. grew its position in shares of Roche by 2.6% during the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company’s stock valued at $518,000 after acquiring an additional 314 shares during the period. Rhumbline Advisers raised its holdings in Roche by 7.4% in the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock worth $4,413,000 after purchasing an additional 7,374 shares during the period. Finally, Boston Common Asset Management LLC grew its holdings in Roche by 10.0% during the first quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company’s stock valued at $13,369,000 after purchasing an additional 29,522 shares during the period.
About Representative Westerman
Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas’ 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas’ 4th Congressional District. He declared candidacy for the 2026 election.
Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.
Roche Company Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Articles
- Five stocks we like better than Roche
- 3 Warren Buffett Stocks to Buy Now
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?